Taconic Biosciences Launches First and Only Super Immunodeficient Mouse Models Lacking Residual Murine Fc Gamma Receptors, for Improved Antibody Therapy Assessment FcResolv™ NOG Models Provide Greater Clarity and More Translatable Data GlobeNewswire October 24, 2022 RENSSELAER, N.Y., Oct. 24, 2022 (GLOBE NEWSWIRE) Taconic Biosciences, a global leader in providing drug discovery.